Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Colorado, Denver
Case Comprehensive Cancer Center
Maastricht University Medical Center
Providence Health & Services
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of California, San Diego
The Clatterbridge Cancer Centre NHS Foundation Trust
University of Pittsburgh
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
UNICANCER
University of Cincinnati
University Hospital, Ghent
Dana-Farber Cancer Institute
The Netherlands Cancer Institute
Jules Bordet Institute
University of California, San Diego
Attikon Hospital